, melanoma patients is followed by increased frequencies of additional Melan-A-specifi c T cells, J. Immunol, vol.175, pp.4797-4805

H. Benlalam, V. Vignard, A. Khammari, A. Bonnin, Y. Godet et al., Infusion of Melan-A/Mart-1 specifi c tumor-infi ltrating lymphocytes enhanced relapse-free survival of melanoma patients, Cancer Immunol. Immunother, vol.56, pp.515-526, 2007.

C. Yee, J. A. Thompson, D. Byrd, S. R. Riddell, P. Roche et al., Adoptive T cell therapy using antigen-specifi c CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor eff ect of transferred T cells, Proc. Natl. Acad. Sci. USA, vol.99, pp.16168-16173, 2002.

B. Dreno, J. M. Nguyen, A. Khammari, M. C. Pandolfi-no, M. H. Tessier et al., Randomized trial of adoptive transfer of melanoma tumor-infi ltrating lymphocytes as adjuvant therapy for stage III melanoma, Cancer Immunol. Immunother, vol.51, pp.539-546, 2002.

N. Labarriere, M. C. Pandolfi-no, N. Gervois, A. Khammari, M. H. Tessier et al., Therapeutic effi cacy of melanoma-reactive TIL injected in stage III melanoma patients, Cancer Immunol. Immunother, vol.51, pp.532-538, 2002.

A. Khammari, J. M. Nguyen, M. C. Pandolfi-no, G. Quereux, A. Brocard et al., Long-term follow-up of patients treated by adoptive transfer of melanoma tumor-infi ltrating lymphocytes as adjuvant therapy for stage III melanoma, Cancer Immunol. Immunother, vol.56, pp.1853-1860, 2007.

H. Benlalam, N. Labarriere, B. Linard, L. Derre, E. Diez et al., Comprehensive analysis of the frequency of recognition of melanoma-associated antigen (MAA) by CD8 melanoma infi ltrating lymphocytes (TIL): implications for immunotherapy, Eur. J. Immunol, vol.31, pp.2007-2015, 2001.

E. Godefroy, A. Moreau-aubry, E. Diez, B. Dreno, F. Jotereau et al., ? v ? 3-dependent cross-presentation of matrix metalloproteinase -2 by melanoma cells gives rise to a new tumor antigen, J. Exp. Med, vol.202, pp.61-72, 2005.

, Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences, Proc. Natl. Acad. Sci. USA, vol.99, pp.16899-16903, 2002.

J. C. Venter, M. D. Adams, E. W. Myers, P. W. Li, R. J. Mural et al., The sequence of the human genome, Science, vol.291, pp.1304-1351, 2001.
URL : https://hal.archives-ouvertes.fr/hal-00465088

N. Labarriere, N. Gervois, A. Bonnin, R. Bouquie, F. Jotereau et al., PBMC are as good a source of tumor-reactive T lymphocytes as TIL after selection by Melan-A/A2 multimer immunomagnetic sorting, Cancer Immunol. Immunother, vol.57, pp.185-195, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-00167752

C. M. Grozinger, C. A. Hassig, and S. L. Schreiber, Three proteins defi ne a class of human histone deacetylases related to yeast Hda1p, Proc. Natl. Acad. Sci. USA, vol.96, pp.4868-4873, 1999.

T. Boon, P. G. Coulie, B. J. Van-den-eynde, and P. Van-der-bruggen, Human T cell responses against melanoma, Annu. Rev. Immunol, vol.24, pp.175-208, 2006.

P. G. Coulie, V. Brichard, A. Van-pel, T. Wolfel, J. Schneider et al., A new gene coding for a diff erentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas, J. Exp. Med, vol.180, pp.35-42, 1994.

V. Brichard, A. Van-pel, T. Wolfel, C. Wolfel, E. De-plaen et al., The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas, J. Exp. Med, vol.178, pp.489-495, 1993.

P. A. Savage, K. Vosseller, C. Kang, K. Larimore, E. Riedel et al., Recognition of a ubiquitous self antigen by prostate cancer-infi ltrating CD8+ T lymphocytes, Science, vol.319, pp.215-220, 2008.

D. Smet, C. , A. Loriot, and T. Boon, Promoter-dependent mechanism leading to selective hypomethylation within the 5 ? region of gene MAGE-A1 in tumor cells, Mol. Cell. Biol, vol.24, pp.4781-4790, 2004.

J. Du, A. J. Miller, H. R. Widlund, M. A. Horstmann, S. Ramaswamy et al., MLANA/MART1 and SILV, 2003.

, de Recherche 26 for the production of HLA -peptide complexes, and C. Gratas for helpful assistance in qPCR experiments

Y. Kawakami, S. Eliyahu, C. H. Delgado, P. F. Robbins, K. Sakaguchi et al., Identifi cation of a human melanoma antigen recognized by tumor-infi ltrating lymphocytes associated with in vivo tumor rejection, Proc. Natl. Acad. Sci. USA, vol.91, pp.6458-6462, 1994.

P. Van-der-bruggen, C. Traversari, P. Chomez, C. Lurquin, E. De-plaen et al., A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma, Science, vol.254, pp.1643-1647, 1991.

B. Gaugler, B. Van-den-eynde, P. Van-der-bruggen, P. Romero, J. J. Gaforio et al., Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes, J. Exp. Med, vol.179, pp.921-930, 1994.

T. Wolfel, M. Hauer, J. Schneider, M. Serrano, C. Wolfel et al., A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma, Science, vol.269, pp.1281-1284, 1995.

J. H. Kessler, N. J. Beekman, S. A. Bres-vloemans, P. Verdijk, P. A. Van-veelen et al., Effi cient identifi cation of novel HLA-A(*)0201 -presented cytotoxic T lymphocyte epitopes in the widely expressed tumor antigen PRAME by proteasome-mediated digestion analysis, J. Exp. Med, vol.193, pp.73-88, 2001.

Y. Guilloux, S. Lucas, V. G. Brichard, A. Van-pel, C. Viret et al., A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanomas is encoded by an intron sequence of the N-acetylglucosaminyltransferase V gene, J. Exp. Med, vol.183, pp.1173-1183, 1996.

A. Moreau-aubry, S. L. Guiner, N. Labarriere, M. C. Gesnel, F. Jotereau et al., A processed pseudogene codes for a new antigen recognized by a CD8 + T cell clone on melanoma, J. Exp. Med, vol.191, pp.1617-1624, 2000.

E. Jager, M. Maeurer, H. Hohn, J. Karbach, D. Jager et al., Clonal expansion of Melan A-specifi c cytotoxic T lymphocytes in a melanoma patient responding to continued immunization with melanoma-associated peptides, Int. J. Cancer, vol.86, pp.538-547, 2000.

E. Jager, H. Hohn, A. Necker, R. Forster, J. Karbach et al., Peptide-specifi c CD8+ T-cell evolution in vivo: response to peptide vaccination with Melan-A/MART-1, Int. J. Cancer, vol.98, pp.376-388, 2002.

M. E. Dudley, J. R. Wunderlich, P. F. Robbins, J. C. Yang, P. Hwu et al., Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes, Science, vol.298, pp.850-854, 2002.

A. Mackensen, N. Meidenbauer, S. Vogl, M. Laumer, J. Berger et al., Phase I study of adoptive T-cell therapy using antigen-specifi c CD8+ T cells for the treatment of patients with metastatic melanoma, J. Clin. Oncol, vol.24, pp.5060-5069, 2006.

N. Meidenbauer, J. Marienhagen, M. Laumer, S. Vogl, J. Heymann et al., Survival and tumor localization of adoptively transferred Melan-A-specifi c T cells in melanoma patients, J. Immunol, vol.170, pp.2161-2169, 2003.

V. Vignard, B. Lemercier, A. Lim, M. C. Pandolfi-no, Y. Guilloux et al., Adoptive transfer of tumor-reactive Melan-A-specifi c CTL clones are transcriptionally regulated by MITF in melanocytes and melanoma, Am. J. Pathol, vol.163, pp.333-343, 2005.

N. J. Bentley, T. Eisen, and C. R. Goding, Melanocyte-specifi c expression of the human tyrosinase promoter: activation by the microphthalmia gene product and role of the initiator, Mol. Cell. Biol, vol.14, pp.7996-8006, 1994.

M. C. Pandolfi-no, N. Labarriere, M. H. Tessier, A. Cassidanius, S. Bercegeay et al., Highscale expansion of melanoma-reactive TIL by a polyclonal stimulus: predictability and relation with disease advancement, Cancer Immunol. Immunother, vol.50, pp.134-140, 2001.

F. Jotereau, M. C. Pandolfi-no, D. Boudart, E. Diez, B. Dreno et al., High-fold expansion of human cytotoxic T-lymphocytes specifi c for autologous melanoma cells for use in immunotherapy, J. Immunother, vol.10, pp.405-411, 1991.

N. Gervois, N. Labarriere, S. L. Guiner, M. C. Pandolfi-no, J. F. Fonteneau et al., High avidity melanoma-reactive cytotoxic T lymphocytes are effi ciently induced from peripheral blood lymphocytes on stimulation by peptidepulsed melanoma cells, Clin. Cancer Res, vol.6, pp.1459-1467, 2000.

T. Espevik and J. Nissen-meyer, A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes, J. Immunol. Methods, vol.95, pp.99-105, 1986.

T. Jung, U. Schauer, C. Heusser, C. Neumann, and C. Rieger, Detection of intracellular cytokines by fl ow cytometry, J. Immunol. Methods, vol.159, pp.197-207, 1993.

M. W. Pfaffl, I. G. Lange, A. Daxenberger, and H. H. Meyer, Tissue-specifi c expression pattern of estrogen receptors (ER): quantifi cation of ER alpha and ER beta mRNA with real-time RT-PCR, APMIS, vol.109, pp.345-355, 2001.

M. Bodinier, M. A. Peyrat, C. Tournay, F. Davodeau, F. Romagne et al., Effi cient detection and immunomagnetic sorting of specifi c T cells using multimers of MHC class I and peptide with reduced CD8 binding, Nat. Med, vol.6, pp.707-710, 2000.